This book chapter advances SDG 3 and 10 by describing and discussing (1) the existing evidence examining associations between mental health and technology use including depression, anxiety, body dissatisfaction, attention-deficit disorders (and risks of distraction), and addictive behaviors and (2) the impacts of risky online communities on adolescents’ mental health, focusing on networks promoting proeating disorder behaviors and prosuicidality.
Elsevier,
Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, Volume , 1 January 2020
This book chapter advances SDG #3 and #10 by outlining how both the asymptomatic and symptomatic predementia phases of AD, amyloid positivity using amyloid PET imaging could predict progression to AD dementia. Amyloid PET imaging can identify the status of Aβ deposition in the underlying AD pathophysiology, increase diagnostic certainty, and alter management. This approach could improve the diagnose and management for patients with memory loss or cognitive dysfunction.
Elsevier,
Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, Volume , 1 January 2020
This book chapter advances SDG #3 and #10 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD).
This book chapter advances SDG #3 and #10 by reviewing background on neurocognitive disorders, approaches to diagnosis, and management of several of the more problematic psychiatric complications of dementia. Disorders reviewed include AD, vascular dementia, Lewy body disease, and frontotemporal dementia. Psychiatric symptoms reviewed include apathy, agitation, psychosis, depression, and anxiety.
Elsevier,
Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, Volume , 1 January 2020
This book chapter advances SDG #3 and #10 by providing an overview of natural AChE inhibitors extracted from plants and their therapeutic potential to treat AD.
This book chapter advances SDG 3 and 10 by providing best practices and applied examples to instruct human factors practitioners (researchers and designers) in creating health-care designs that are inclusive of various populations.
This book chapter advances SDG 3 and 10 by exploring the current state of design as applied to global health, models of how it is carried out, and some of the questions that arise for practitioners. The goal of this chapter is to help practioners design models to help improve health and well-being of people in lower income countries.
Elsevier,
Contemporary Psychodynamic Psychotherapy: Evolving Clinical Practice, Volume , 18 June 2019
This book chapter advances SDG 3 and 10 by reviewing most relevant psychodynamic and developmental theories and empirical analyses for LGBT communities.
Neurochemical Aspects of Alzheimer's Disease Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies, 2017, Pages 47-91
This book chapter advances SDG #3 and #10 by reviewing the risk factors for Alzheimer’s Disease, including normal aging, diet, sedentary lifestyle, sleep disturbances, genes [amyloid precursor protein (APP), presenilin 1 (PSEN1), PSEN2, and APOE], environmental factors, and epigenetic factors.
This book chapter advances SDG #3 and #10 by reviewing neural regeneration–based therapeutic approaches as it represents a highly promising therapeutic strategy for AD, including research that CNTF small-molecule peptide mimetic has demonstrated that neural regeneration–based strategy can also be disease modifying for AD.
